Dr. Sundhar Ramalingam
Overview
I mainly treat patients with genitourinary cancers including prostate, kidney, bladder, testicular and penile cancer. My goal is to be attentive and devoted to my patients who are often dealing with complicated health problems. I try to personalize my care because every patient is different. I believe the future is promising because new treatments are being discovered every day. I am involved in clinical trials done through Duke University. Clinical trials are designed to provide patients with access to the newest possible treatments. I am also part of our multi-disciplinary cancer team including urologic oncologists, geneticists, radiation oncologists, pathologists, radiologists, and other specialists. I grew up in Cary and did all of my medical training in the Research Triangle Park area. I feel honored to practice in the same community I have lived in for more than twenty-five years.
Dr. Ramalingam is rated as an Experienced provider by MediFind in the treatment of Astrocytoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Multiple Myeloma.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
216 Ashville Ave, Cary, NC 27518
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Cancer Center Brain Tumor Clinic
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Astrocytoma. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
Duke Health Integrated Practice Inc
David Ashley is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Ashley is rated as an Elite provider by MediFind in the treatment of Astrocytoma. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Ashley is currently accepting new patients.
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Astrocytoma. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Brain Tumor, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerDr. Ramalingam isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Ramalingam isDistinguished. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Advanced
- Adult T-Cell LeukemiaDr. Ramalingam isAdvanced. Learn about Adult T-Cell Leukemia.
- Chronic T-Cell Leukemia (CTCL)Dr. Ramalingam isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Large-Cell Immunoblastic LymphomaDr. Ramalingam isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Ramalingam isAdvanced. Learn about Multiple Myeloma.
- Non-Muscle Invasive Bladder CancerDr. Ramalingam isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Adult Immune ThrombocytopeniaDr. Ramalingam isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Ramalingam isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ramalingam isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Ramalingam isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Ramalingam isExperienced. Learn about Antiphospholipid Syndrome.
- Arterial EmbolismDr. Ramalingam isExperienced. Learn about Arterial Embolism.